ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
NOVOZYMES A/S: cashflow_investing
One fact, its scope and the complete path back to the official record.
Reported value
-24.400M{"amount": -24400000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}- Entity
- NOVOZYMES A/S
- Metric
- cashflow_investing
- Period
- 2024-04-01 – 2024-06-30
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2025-06-30Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:02:05.150702+02:00
Raw response SHA-256
c8e95e08e2a4ef338b66b87733882a24…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.